|
13.06.2014 14:29:06
|
Protalix BioTherapeutics CEO David Aviezer To Retire - Quick Facts
(RTTNews) - Protalix BioTherapeutics Inc. (PLX) announced that David Aviezer has decided to retire after almost 12 years from his role as the Company's President and Chief Executive Officer. He will retire this year upon the completion of a process to nominate his successor.
In the meantime, Aviezer will continue serving as President and Chief Executive Officer and remains a member of the Board of Directors.
The company's Board will appoint a committee to select a new Chief Executive Officer.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.